Centre India Pharma Private Limited
About Centre India Pharma Private Limited
Data last updated:
Centre India Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC369381. Its GSTIN is 09AAICC9497Q1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rohit Sachdeva and Eshan Gulati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 2/71 Ground Floor Safdarjung Enclave, New Delhi, Delhi, India – 110029.
As per the financials filed for FY 2025, the company reported a revenue of ₹61,600, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹2.23 Lakh (net margin -362.2%) and EBITDA of -₹2.23 Lakh (EBITDA margin -362.2%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years.
Company details
Contact details
Centre India Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB – 2/71 Ground Floor Safdarjung Enclave, New Delhi, Delhi, India – 110029
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Centre India Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Centre India Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Centre India Pharma Private Limited, buy the company report.
Financials of Centre India Pharma Private Limited
FY 2025 filings availableCentre India Pharma Private Limited reported revenue of ₹61,600 (down 94% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 62% over three years, including a 94% fall in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -362.2% | ||||
| Net Profit Margin | -362.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Centre India Pharma Private Limited, buy the company report.
Board of directors of Centre India Pharma Private Limited
Centre India Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Sachdeva Also directs: Glow Worms Engineering Private Limited | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
| Eshan Gulati Also directs: Gulatee Marketing LLP | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
| Vinamr L Sachdeva | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
| Praveen Gulatee Also directs: Gulatee Marketing LLP | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Centre India Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Buckerry India Private Limited | ₹61,690 (FY 2025) | -41.0% | Udaipur, Rajasthan, India | |||
| Boost and Earn Private Limited | ₹61,684 (FY 2022) | 56.0% | Raisen, Madhya Pradesh, India | |||
| Gateway Venture Capital Limited | ₹61,684 (FY 2025) | -75.0% | Kolkata, West Bengal, India | |||
| Nandan Therapeutics Private Limited | ₹61,617 (FY 2024) | 93.0% | Hyderabad, Telangana, India | |||
| Centre India Pharma Private Limitedthis company | ₹61,600 (FY 2025) | -₹2.23 Lakh | -362.2% | -94.0% | New Delhi, Delhi, India | |
| Faith Electric Motors Private Limited | ₹61,600 (FY 2024) | -76.0% | Kolkata, West Bengal, India | |||
| Ekeekaran Ventures Private Limited | ₹61,590 (FY 2020) | Ranchi, Jharkhand, India | ||||
| Indica Polymers Private Limited | ₹61,575 (FY 2025) | -66.0% | Bengaluru, Karnataka, India | |||
| Earthmusk Private Limited | ₹61,544 (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Inocist Solutions Private Limited | ₹61,500 (FY 2024) | 64.0% | Kolkata, West Bengal, India | |||
| Risingstars Polytex Private Limited | ₹61,450 (FY 2025) | 101.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Centre India Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Centre India Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Centre India Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Centre India Pharma Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Centre India Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC9497Q1ZE | Uttar Pradesh | Active | 13 Oct 2020 |
To see the full GST registrations and return filing status of Centre India Pharma Private Limited, buy the company report.
Recent activity
Centre India Pharma Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Eshan Gulati was appointed as Director on 05 Sep 2020.
Frequently asked questions
Centre India Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U51909DL2020PTC369381.
Centre India Pharma has 4 current directors:
- Rohit Sachdeva - Director
- Eshan Gulati - Director
- Vinamr L Sachdeva - Director
- Praveen Gulatee - Director
The latest financial statements of Centre India Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Centre India Pharma is 09AAICC9497Q1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Centre India Pharma is U51909DL2020PTC369381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centre India Pharma was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Centre India Pharma by revenue are Buckerry India Private Limited, Boost and Earn Private Limited, Gateway Venture Capital Limited, Nandan Therapeutics Private Limited, Faith Electric Motors Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Eshan Gulati was appointed as Director on 05 Sep 2020. Praveen Gulatee was appointed as Director on 05 Sep 2020. Rohit Sachdeva was appointed as Director on 05 Sep 2020. Centre India Pharma has 4 board changes on record in total.
The registered office of Centre India Pharma is at B – 271 Ground Floor Safdarjung Enclave, New Delhi, Delhi, India – 110029.
Centre India Pharma operates in the trading industry, in the specialty segment.
Centre India Pharma can be reached at its registered office: B – 271 Ground Floor Safdarjung Enclave, New Delhi, Delhi, India – 110029.